Your browser doesn't support javascript.
loading
Activity of rifampicin and linezolid combination in Mycobacteriumtuberculosis
Maltempe, Flaviane Granero; Caleffi-Ferracioli, Katiany Rizzieri; do Amaral, Renata Claro Ribeiro; de Oliveira Demitto, Fernanda; Siqueira, Vera Lucia Dias; de Lima Scodro, Regiane Bertin; Hirata, Mario Hiroyuki; Pavan, Fernando Rogerio; Cardoso, Rosilene Fressatti.
Afiliação
  • Maltempe, Flaviane Granero; State University of Maringa. Maringá. BR
  • Caleffi-Ferracioli, Katiany Rizzieri; State University of Maringa. Maringá. BR
  • do Amaral, Renata Claro Ribeiro; State University of Maringa. Maringá. BR
  • de Oliveira Demitto, Fernanda; State University of Maringa. Maringá. BR
  • Siqueira, Vera Lucia Dias; State University of Maringa. Maringá. BR
  • de Lima Scodro, Regiane Bertin; State University of Maringa. Maringá. BR
  • Hirata, Mario Hiroyuki; School of Pharmaceutical Sciences. University of Sao Paulo. São Paulo. BR
  • Pavan, Fernando Rogerio; School of Pharmaceutical Sciences. Paulista State University. Araraquara. BR
  • Cardoso, Rosilene Fressatti; State University of Maringa. Maringá. BR
Tuberculosis (Edinb) ; 104: 24-29, 2017. tab, graf
Artigo em Inglês | Sec. Est. Saúde SP, SESSP-IDPCPROD, Sec. Est. Saúde SP | ID: biblio-1068316
Biblioteca responsável: BR79.1
Localização: BR79.1
ABSTRACT

Background:

Linezolid (LZD) is not commonly used for treating tuberculosis (TB), but in some patients with drug-resistant TB it is being used. However, the in vitro LZD activity, in combination with rifampicin (RIF) against Mycobacterium tuberculosis has not been fully elucidated.

Aims:

The aim of this study was to evaluate the in vitro activity of RIF/LZD combination against M. tuberculosis clinical isolates.Materials and

methods:

The activity of the RIF/LZD combination was firstly determined in M. tuberculosis H37Rv, 14 susceptible, 9 isoniazid nonresistant and 14 multi-drug resistant (MDR) M. tuberculosis clinical isolates by modified checkerboard assay, Resazurin Drugs Combination Microtiter Assay (REDCA). After, the Time Kill Curve Assay, at 0.5 MIC of drugs, in combination and alone, was performed in M. tuberculosis H37Rv and 8 (20.5%) of those clinical isolates, which the RIF/LZD combination showed to have synergistic effect by the checkerboard assay.Results and

conclusion:

By Time Kill Curve Assay, we could observe in M. tuberculosis H37Rv and susceptible isolates, that LZD alone, at sub inhibitory concentration, has poor effect on the bacillus death. In some cases, the bacillus growth stayed constant while in others showed regrowth at the eighth day ofdrug exposure. RIF alone exhibits potent concentration-dependent bactericidal activity, and was strongly dependent by the drug exposure time. The RIF/LZD combination accomplished a bacteriostatic effect in the reference strain and susceptible isolates. For the RIF resistant isolates, the RIF/LZD combination did not enhance the effect in killing bacillus. In this sense, additional, in vitro and in vivo studies are needed to evaluate the effect of RIF/LZD combination in order to better understand the adjunctive action of LZD in the treatment of TB and prevent the emergence of mutants with resistance to the available anti-TB drugs.
Assuntos

Buscar no Google
Coleções: Bases de dados nacionais / Brasil Contexto em Saúde: Doenças Negligenciadas Problema de saúde: Doenças Negligenciadas / Tuberculose Base de dados: Sec. Est. Saúde SP / SESSP-IDPCPROD Assunto principal: Tuberculose / Tuberculose Resistente a Múltiplos Medicamentos / Tratamento Farmacológico Idioma: Inglês Revista: Tuberculosis (Edinb) Ano de publicação: 2017 Tipo de documento: Artigo Instituição/País de afiliação: School of Pharmaceutical Sciences/BR / State University of Maringa/BR
Buscar no Google
Coleções: Bases de dados nacionais / Brasil Contexto em Saúde: Doenças Negligenciadas Problema de saúde: Doenças Negligenciadas / Tuberculose Base de dados: Sec. Est. Saúde SP / SESSP-IDPCPROD Assunto principal: Tuberculose / Tuberculose Resistente a Múltiplos Medicamentos / Tratamento Farmacológico Idioma: Inglês Revista: Tuberculosis (Edinb) Ano de publicação: 2017 Tipo de documento: Artigo Instituição/País de afiliação: School of Pharmaceutical Sciences/BR / State University of Maringa/BR
...